C-DIAS RP3: Scaling-out app-based treatments: a multi-level strategy to promote equity across primary care patients with substance use
C-DIAS RP3:扩展基于应用程序的治疗:促进初级保健药物使用患者公平的多层次策略
基本信息
- 批准号:10668496
- 负责人:
- 金额:$ 39.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdherenceAdvisory CommitteesAfrican AmericanAsian AmericansAuthorization documentationBlack AmericanBuprenorphineCaringCellular PhoneClinicCollaborationsCommunicationCommunity Health SystemsDataDevicesDisparityDisparity populationDissemination and ImplementationEngineeringEnsureEquityEthicsEthnic OriginEvidence based practiceEvidence based treatmentFailureFeedbackGlassHealth Services AccessibilityHealth systemHealthcareHealthcare SystemsHispanicHomeHuman ResourcesIndividualInequityInterventionLaboratoriesLanguageLatinoLeadershipLearningMedicineMental Health ServicesMentorsMethodologyModelingOutcomeOwnershipPatient CarePatient-Focused OutcomesPatientsPerceptionPerformancePersonsPhasePopulation HeterogeneityPrimary CarePrivacyPrivatizationProblem SolvingPublic HealthRaceRandomizedResearchResearch DesignResearch PersonnelResearch Project GrantsRoleService provisionStatistical MethodsSubstance Use DisorderSystemTestingTimeUnited States National Academy of SciencesUnited States National Institutes of HealthVisitWashingtonWorld Healthaddictionauthoritybrief interventioncomorbiditycostdata harmonizationdesigndigitaldigital healthdigital healthcaredigital treatmentdisparity reductioneffectiveness/implementation hybridhealth disparity populationshealth equityhigh riskimplementation contextimplementation costimplementation evaluationimplementation outcomesimplementation scienceimplementation strategyimplementation studyimprovedinnovationmemberpatient subsetspragmatic trialprimary care clinicprimary care clinicianprimary care patientprimary care teamprimary care visitsocial determinantssocial stigmastandardize measurestemsubstance usesubstance use treatmentsuccessweb-based intervention
项目摘要
C-DIAS RESEARCH PROJECT 3: PROJECT SUMMARY/ABSTRACT
At the SUSTAIN phase, C-DIAS Research Project 3 addresses a critical scientific and public health gap: How
can we improve equity when offering digital treatments to patients with substance use disorders (SUDs) in
primary care? A wide range of effective digital treatments —app or web-based interventions—for SUDs and
comorbid conditions are available for use in primary care, and many have been evaluated in diverse
populations. Digital treatments for SUDs could potentially reduce inequities, as they: 1) have the potential to
reach more people by reducing access barriers; 2) can circumvent SUD stigma; and 3) allow patients to initiate
interventions from the comfort and privacy of home. At the same time, digital treatments may also magnify
inequities due to factors stemming from the “digital divide.” We will rigorously evaluate an implementation
strategy to “scale-out” digital treatments to disadvantaged populations as an approach to potentially improve
equity in digital care for people with SUDs, and as a model for how to ethically sustain digital treatments in
real-world healthcare. Prior pragmatic trials found that evidence-based practices and other initiatives are hard
to sustain without leadership and clinic buy-in, so our multi-level study design and analytic plan focuses on
these issues. Our delivery system partners in Kaiser Permanente Washington are committed to collaborating
with us to study multi-level strategies for scaling-out existing digital treatments in 32 primary care clinics in
Washington State to address expected equity challenges. All clinics will receive a 3-part system-level set of
implementation strategies that are suitable for primary care: 1) system-wide audit and feedback; 2) patient
stories from members of disadvantaged populations; and, 3) engaging key stakeholders in problem solving to
reduce barriers to the use of digital treatments among disadvantaged populations. To test a clinic-level
implementation strategy, a subset of 12 clinics will be randomized to receive external facilitation or to a control
condition (no facilitation) in a 1:1 parallel-groups design. Equity outcomes will be assessed by comparing reach
across subgroups of patients defined by key social determinants (e.g., race/ethnicity). Specific Aims are to: 1)
estimate the impact of a multi-level implementation strategy (system- and clinic-level) in increasing equity in
the reach of digital treatments among patients with SUD in primary care clinics; and 2) describe the costs of
and adherence to the implementation strategies, and examine how contextual determinants can impact equity
in implementation and patient outcomes. Research Project 3 leverages a bi-directional relationship with C-
DIAS, demonstrated in part by: 1) standardized measures of implementation context, outcomes and procedural
details of strategies; 2) PI (Glass)’s role on the C-DIAS Research Core; 3) a close network of collaboration and
mentoring among the key project personnel and C-DIAS PI; 4) harmonization of data that can be used for
modeling by C-DIAS Research Core experts; 5) data on digital treatment implementation costs for decision-
makers; and 6) expanded options for dissemination and impact of study findings through C-DIAS.
C-DIAS研究项目3:项目摘要/摘要
在维持阶段,C-DIAS研究项目3解决了一个关键的科学和公共卫生差距:如何
在向物质使用障碍(SODS)患者提供数字治疗时,我们能否提高公平性
初级保健?一系列有效的数字治疗-应用程序或基于网络的干预-针对肥皂泡和
在初级保健中可以使用并存的情况,许多情况已经在不同的情况下进行了评估
人口。肥皂水的数字化治疗可能会潜在地减少不平等,因为它们:1)有可能
通过减少访问障碍接触到更多的人;2)可以避免SUD耻辱;以及3)允许患者发起
来自家庭舒适性和私密性的干预。与此同时,数字化治疗也可能放大
由于“数字鸿沟”的因素造成的不平等。我们将严格评估一项实施
向弱势群体“向外扩展”数字治疗的战略,作为潜在改善的一种方法
为肥皂泡患者提供数字护理方面的公平,并作为如何在道德上维持数字治疗的典范
现实世界的医疗保健。先前的务实试验发现,基于证据的做法和其他主动行动是困难的
在没有领导和临床支持的情况下维持,因此我们的多层次研究设计和分析计划专注于
这些问题。我们在华盛顿州凯撒永久的交付系统合作伙伴致力于合作
与我们一起研究多层次战略,以便在#年的32家初级保健诊所扩展现有的数字治疗
华盛顿州应对预期的股权挑战。所有诊所将获得一套由三部分组成的系统级别的
适用于初级保健的实施策略:1)全系统审计和反馈;2)患者
弱势群体成员的故事;以及,3)让关键利益攸关方参与解决问题,以
减少弱势群体使用数字治疗的障碍。测试一个诊所的水平
实施战略,12个诊所的子集将随机接受外部促进或对照
1:1平行分组设计中的条件(无促进)。股权结果将通过比较REACH进行评估
跨由关键社会决定因素(例如种族/民族)定义的患者亚群。具体目标是:1)
评估多层次实施战略(系统和诊所级别)在提高
初级保健诊所中SUD患者的数字化治疗覆盖范围;以及2)描述
以及对实施战略的坚持,并审查背景决定因素如何影响公平
在实施和患者结果方面。研究项目3利用与C-
DIAS,部分表现为:1)执行背景、结果和程序的标准化措施
战略细节;2)PI(玻璃)在C-DIAS研究核心中的S作用;3)密切的合作网络和
在关键项目人员和C-DIAS PI之间进行指导;4)协调可用于
由C-DIAS研究核心专家建模;5)用于决策的数字治疗实施成本数据-
6)通过C-DIAS扩大研究结果的传播和影响的选择范围。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph Edwin Glass其他文献
Joseph Edwin Glass的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph Edwin Glass', 18)}}的其他基金
C-DIAS RP3: Scaling-out app-based treatments: a multi-level strategy to promote equity across primary care patients with substance use
C-DIAS RP3:扩展基于应用程序的治疗:促进初级保健药物使用患者公平的多层次策略
- 批准号:
10493961 - 财政年份:2022
- 资助金额:
$ 39.23万 - 项目类别:
Multi-level Influences of Alcohol Based Quality and Outcome Measures
酒精质量的多层次影响和结果测量
- 批准号:
10704144 - 财政年份:2022
- 资助金额:
$ 39.23万 - 项目类别:
Multi-level Influences of Alcohol Based Quality and Outcome Measures
酒精质量的多层次影响和结果测量
- 批准号:
10590820 - 财政年份:2022
- 资助金额:
$ 39.23万 - 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
- 批准号:
10092143 - 财政年份:2019
- 资助金额:
$ 39.23万 - 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
- 批准号:
10349443 - 财政年份:2019
- 资助金额:
$ 39.23万 - 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
- 批准号:
9902391 - 财政年份:2019
- 资助金额:
$ 39.23万 - 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
- 批准号:
10560538 - 财政年份:2019
- 资助金额:
$ 39.23万 - 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: Observational Analysis of Adaptions to the Intervention
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字化治疗:干预措施适应的观察分析
- 批准号:
10652751 - 财政年份:2019
- 资助金额:
$ 39.23万 - 项目类别:
Decreasing the Engagement Gap for Addiction Treatment in Primary Care
缩小初级保健中成瘾治疗的参与差距
- 批准号:
9981556 - 财政年份:2017
- 资助金额:
$ 39.23万 - 项目类别:
Decreasing the Engagement Gap for Addiction Treatment in Primary Care
缩小初级保健中成瘾治疗的参与差距
- 批准号:
10222485 - 财政年份:2017
- 资助金额:
$ 39.23万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 39.23万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 39.23万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 39.23万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 39.23万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 39.23万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 39.23万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 39.23万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 39.23万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 39.23万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 39.23万 - 项目类别:
Fellowship Programs